{"podcast":{"title":"Innovate and Elevate","slug":"innovate-and-elevate-6703724","podcast_index_feed_id":6703724,"rss_url":"https://feeds.captivate.fm/innovate-and-elevate/","website_url":"https://www.innovateandelevatepodcast.com/","image_url":"https://artwork.captivate.fm/d938c490-9603-45d4-976a-1d4a22816fd1/Innovate-and-Elevate-Podcast-Cover-Season-3.jpg","author":"Sharon Kedar, MBA, CFA","episode_count":26,"summary":"Join Sharon Kedar, Co-Founder of Northpond Ventures, as she has candid, in-depth conversations with top doctors, scientists, and trailblazing innovators. Innovate and Elevate is the podcast where the pioneering ideas and leading-edge discoveries that redefine human health are explored. Behind every revolutionary method and device is a human, or humans, daring to make the impossible possible. Sharon, an investor at the forefront of science-driven venture capital, talks with these change agents about how they are rewriting the rules in their fields - from human health and longevity to breakthrough diagnostics and therapeutics. Featured by Harvard’s Wyss Institute, this podcast delivers the sophisticated, knowledgeable, and essential insights you need to understand how innovation impacts our lives. Because Humanity Deserves Better. Sharon Kedar is Co-Founder, Partner of Northpond Ventures. She is also a human health advocate and has been invited to and spoken at notable institutions and events nationwide, including The New York Stock Exchange, The White House, ARPA-H, and Harvard University. “This new podcast is just what I needed- a platform to learn about health and innovation. I j…","last_synced_at":"2026-07-30T18:20:02.647175+00:00","page_url":"https://stenobird.com/podcast/innovate-and-elevate-6703724"},"episode":{"title":"8 Days After the FDA: Breaking Down HRT and Breast Cancer Risk with Dr. Corinne Menn","slug":"8-days-after-the-fda-breaking-down-hrt-and-breast-cancer-risk-with-dr-corinne-menn","published_at":"2025-11-26T09:00:00+00:00","page_url":"https://stenobird.com/podcast/innovate-and-elevate-6703724/8-days-after-the-fda-breaking-down-hrt-and-breast-cancer-risk-with-dr-corinne-menn","show_page_url":"https://stenobird.com/podcast/innovate-and-elevate-6703724","url":"https://www.innovateandelevatepodcast.com/","audio_url":"https://episodes.captivate.fm/episode/c130540b-14a0-427b-9c3f-60741f2da98a.mp3","summary":"On this episode of Innovate & Elevate, Sharon sits down with Dr. Corinne Menn, an OB-GYN, menopause specialist, and breast cancer survivor, to unpack one of the most misunderstood topics in women’s health: the relationship between breast cancer risk and hormone therapy. Recorded eight days after the FDA announced it will remove the long-standing black box language on hormone therapy, this conversation traces the legacy of the 2002 Women’s Health Initiative press conference, what the data actually showed, and how modern evidence can better guide women and their clinicians today. What You’ll Learn from this Episode: What really happened in July 2002, and why the WHI press conference (held eight days before doctors saw the full study) reshaped hormone therapy for a generation. The difference between estrogen alone and combined estrogen–progestin therapy, and why age, timing, and formulation matter. Why every major professional society (ASCO, ACOG, American Urological Association, The Menopause Society) agrees that local, low-dose vaginal hormones do not increase breast cancer risk, recurrence, or mortality. The role of tools like the Tyrer–Cuzick breast cancer risk model in understanding your baseline risk - and how Dr. Menn interprets those results in the context of HRT. Dr. Menn’s own story: being diagnosed with ER/PR-positive breast cancer at 28 during OB-GYN residency, going through abrupt menopause, and later discovering a BRCA2 mutation after updated genetic testing How she now counsels breast cancer survivors about menopause, quality of life, and when hormone therapy may or may not be appropriate Practical ways women can prepare for a time-limited doctor’s visit to have more informed, individualized conversations about breast cancer risk and hormone therapy As…","meta_description":"On this episode of Innovate & Elevate, Sharon sits down with Dr. Corinne Menn, an OB-GYN, menopause specialist, and breast cancer survivor, to unpack…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2581,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/innovate-and-elevate-6703724/episodes/8-days-after-the-fda-breaking-down-hrt-and-breast-cancer-risk-with-dr-corinne-menn/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/innovate-and-elevate-6703724/8-days-after-the-fda-breaking-down-hrt-and-breast-cancer-risk-with-dr-corinne-menn.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}